Immunoglobulin deficiencies and susceptibility to infection among homozygotes and heterozygotes for C2 deficiency

被引:30
作者
Alper, CA
Xu, JH
Cosmopoulos, K
Dolinski, B
Stein, R
Uko, G
Larsen, CE
Dubey, DP
Densen, P
Truedsson, L
Sturfelt, G
Sjöholm, AG
机构
[1] Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[3] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[4] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[5] VAMC, Iowa City, IA USA
[6] Lund Univ, Inst Lab Med, Sect Microbiol Immunol & Glycobiol, Lund, Sweden
[7] Lund Univ, Dept Rheumatol, Lund, Sweden
关键词
C2; deficiency; immunodeficiency diseases; infection; MHC;
D O I
10.1023/A:1024540917593
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
About 25% of C2-deficient homozygotes have increased susceptibility to severe bacterial infections. C2-deficient homozygotes had significantly lower serum levels of IgG2, IgG4, IgD, and Factor B, significantly higher levels of IgA and IgG3 and levels of IgG1 and IgM similar to controls. Type I ( 28 bp deletion in C2 exon 6 on the [HLA-B18, S042, DR2] haplotype or its fragments) and type II ( non-type I) C2-deficient patients with increased susceptibility to bacterial infection had significantly lower mean levels of IgG4 ( p < 0.04) and IgA ( p < 0.01) than those without infections ( who had a higher than normal mean IgA level) but similar mean levels of other immunoglobulins and Factor B. Of 13 C2-deficient homozygotes with infections, 85% had IgG4 deficiency, compared with 64% of 25 without infections. IgD deficiency was equally extraordinarily common among infection-prone (50%) and noninfection-prone (70%) homozygous type I C2-deficient patients. IgD deficiency was also common (35%) among 31 type I C2-deficient heterozygotes ( with normal or type II haplotypes), but was not found in 5 type II C2-deficient heterozygotes or 1 homozygote. Thus, C2 deficiency itself is associated with many abnormalities in serum immunoglobulin levels, some of which, such as in IgG4 and IgA, may contribute to increased susceptibility to infection. In contrast, IgD deficiency appears not to contribute to increased infections and appears to be a dominant trait determined by a gene or genes on the extended major histocompatibility complex (MHC) haplotype [HLA-B18, S042, DR2] ( but probably not on type II C2-deficient haplotypes) similar to those previously identified on [HLA-B8, SC01, DR3] and [HLA-B18, F1C30, DR3].
引用
收藏
页码:297 / 305
页数:9
相关论文
共 48 条
[1]  
AGNELLO V, 1972, J IMMUNOL, V108, P837
[2]   Prospective analysis suggests susceptibility genes for deficiencies of IgA and several other immunoglobulins on the [HLA-B8, SCO1, DR3] conserved extended haplotype [J].
Alper, CA ;
Marcus-Bagley, D ;
Awdeh, Z ;
Kruskall, MS ;
Eisenbarth, GS ;
Brink, SJ ;
Katz, AJ ;
Stein, R ;
Bing, DH ;
Bing, DH ;
Yunis, EJ ;
Schur, PH .
TISSUE ANTIGENS, 2000, 56 (03) :207-216
[3]   SERUM COMPLEMENT SUPERGENES OF THE MAJOR HISTOCOMPATIBILITY COMPLEX IN MAN (COMPLOTYPES) [J].
ALPER, CA ;
RAUM, D ;
KARP, S ;
AWDEH, ZL ;
YUNIS, EJ .
VOX SANGUINIS, 1983, 45 (01) :62-67
[4]   Incomplete penetrance of MHC susceptibility genes: prospective analysis of polygenic MHC-determined traits [J].
Alper, CA ;
Awdeh, Z .
TISSUE ANTIGENS, 2000, 56 (03) :199-206
[5]  
AUSTEN KF, 1964, J IMMUNOL, V92, P946
[6]   COMPLEMENT-HUMAN HISTOCOMPATIBILITY ANTIGEN HAPLOTYPES IN C2 DEFICIENCY [J].
AWDEH, ZL ;
RAUM, DD ;
GLASS, D ;
AGNELLO, V ;
SCHUR, PH ;
JOHNSTON, RB ;
GELFAND, EW ;
BALLOW, M ;
YUNIS, E ;
ALPER, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 67 (02) :581-583
[7]   THE REGULATION OF IGG SUBCLASS PRODUCTION IN MAN - LOW SERUM IGG4 IN INHERITED DEFICIENCIES OF THE CLASSICAL PATHWAY OF C-3 ACTIVATION [J].
BIRD, P ;
LACHMANN, PJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (08) :1217-1222
[8]   IgA deficiency [J].
Burrows, PD ;
Cooper, MD .
ADVANCES IN IMMUNOLOGY, VOL 65, 1997, 65 :245-276
[9]   The [HLA-B18, F1C30, DR3] conserved extended haplotype carries a susceptibility gene for IgD deficiency [J].
Calvo, B ;
Castaño, L ;
Marcus-Bagley, D ;
Fici, DA ;
Awdeh, Z ;
Alper, CA .
JOURNAL OF CLINICAL IMMUNOLOGY, 2000, 20 (03) :216-220
[10]  
Carroll M C, 2000, Adv Immunol, V74, P61